These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36229500)

  • 21. High burden of skin sclerosis is associated with severe organ involvement in patients with systemic sclerosis and systemic sclerosis overlap syndrome.
    Wannarong T; Muangchan C
    Rheumatol Int; 2018 Dec; 38(12):2279-2288. PubMed ID: 30206672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a web-based calculator to predict three-month mortality among patients with bone metastases from cancer of unknown primary: An internally and externally validated study using machine-learning techniques.
    Cui Y; Wang Q; Shi X; Ye Q; Lei M; Wang B
    Front Oncol; 2022; 12():1095059. PubMed ID: 36568149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility of hypo- and hyperpigmentation of skin in diffuse cutaneous systemic sclerosis.
    Solanki KK; Hor C; Chang WSJ; Frampton C; White DHN
    Int J Rheum Dis; 2017 Jun; 20(6):767-773. PubMed ID: 28261995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database.
    Maurer B; Graf N; Michel BA; Müller-Ladner U; Czirják L; Denton CP; Tyndall A; Metzig C; Lanius V; Khanna D; Distler O;
    Ann Rheum Dis; 2015 Jun; 74(6):1124-31. PubMed ID: 24981642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can Machine-learning Algorithms Predict Early Revision TKA in the Danish Knee Arthroplasty Registry?
    El-Galaly A; Grazal C; Kappel A; Nielsen PT; Jensen SL; Forsberg JA
    Clin Orthop Relat Res; 2020 Sep; 478(9):2088-2101. PubMed ID: 32667760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
    Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
    Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive model for early functional outcomes following acute care after traumatic brain injuries: A machine learning-based development and validation study.
    Zhang M; Guo M; Wang Z; Liu H; Bai X; Cui S; Guo X; Gao L; Gao L; Liao A; Xing B; Wang Y
    Injury; 2023 Mar; 54(3):896-903. PubMed ID: 36732148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rule-based and machine learning algorithms identify patients with systemic sclerosis accurately in the electronic health record.
    Jamian L; Wheless L; Crofford LJ; Barnado A
    Arthritis Res Ther; 2019 Dec; 21(1):305. PubMed ID: 31888720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting Sepsis Mortality in a Population-Based National Database: Machine Learning Approach.
    Park JY; Hsu TC; Hu JR; Chen CY; Hsu WT; Lee M; Ho J; Lee CC
    J Med Internet Res; 2022 Apr; 24(4):e29982. PubMed ID: 35416785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A methodology for exploring biomarker--phenotype associations: application to flow cytometry data and systemic sclerosis clinical manifestations.
    Huang H; Fava A; Guhr T; Cimbro R; Rosen A; Boin F; Ellis H
    BMC Bioinformatics; 2015 Sep; 16():293. PubMed ID: 26373409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort.
    Jung M; Bonner A; Hudson M; Baron M; Pope JE;
    Scand J Rheumatol; 2014; 43(3):217-20. PubMed ID: 24650305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma.
    Low AHL; Ng SA; Berrocal V; Brennan B; Chan G; Ng SC; Khanna D
    Int J Rheum Dis; 2019 Jun; 22(6):1036-1040. PubMed ID: 30838791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
    Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
    Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An easy prediction rule for diffuse cutaneous systemic sclerosis using only the timing and type of first symptoms and auto-antibodies: derivation and validation.
    van den Hombergh WM; Carreira PE; Knaapen-Hans HK; van den Hoogen FH; Fransen J; Vonk MC
    Rheumatology (Oxford); 2016 Nov; 55(11):2023-2032. PubMed ID: 27550299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
    Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
    Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Machine learning algorithms for early sepsis detection in the emergency department: A retrospective study.
    Kijpaisalratana N; Sanglertsinlapachai D; Techaratsami S; Musikatavorn K; Saoraya J
    Int J Med Inform; 2022 Apr; 160():104689. PubMed ID: 35078027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study.
    Hasegawa M; Asano Y; Endo H; Fujimoto M; Goto D; Ihn H; Inoue K; Ishikawa O; Kawaguchi Y; Kuwana M; Muro Y; Ogawa F; Sasaki T; Takahashi H; Tanaka S; Takehara K; Sato S
    Rheumatology (Oxford); 2012 Jan; 51(1):129-33. PubMed ID: 22072085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development, evaluation and validation of machine learning models to predict hospitalizations of patients with coronary artery disease within the next 12 months.
    Ermak AD; Gavrilov DV; Novitskiy RE; Gusev AV; Andreychenko AE
    Int J Med Inform; 2024 Aug; 188():105476. PubMed ID: 38743996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design.
    Domsic RT; Gao S; Laffoon M; Wisniewski S; Zhang Y; Steen V; Lafyatis R; Medsger TA
    Rheumatology (Oxford); 2021 Oct; 60(10):4662-4670. PubMed ID: 33506859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.